Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,080 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence.
Battiwalla M, Hahn T, Radovic M, Roy H, Wahab A, Duman E, Bajwa R, Padmanabhan S, Becker J, Barrett AJ, McCarthy PL Jr. Battiwalla M, et al. Among authors: becker j. Blood. 2006 Mar 1;107(5):1970-3. doi: 10.1182/blood-2005-05-1958. Epub 2005 Nov 10. Blood. 2006. PMID: 16282347 Free article.
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.
Hahn T, Alam AR, Lawrence D, Ford L, Baer MR, Bambach B, Bernstein ZP, Czuczman MS, Silva J, Slack JL, Wetzler M, Becker J, McCarthy PL Jr. Hahn T, et al. Among authors: becker j. Transplantation. 2004 Nov 27;78(10):1515-22. doi: 10.1097/01.tp.0000141363.81600.0d. Transplantation. 2004. PMID: 15599317
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease.
Hahn T, Benekli M, Wong C, Moysich KB, Hyland A, Michalek AM, Alam A, Baer MR, Bambach B, Czuczman MS, Wetzler M, Becker JL, McCarthy PL. Hahn T, et al. Among authors: becker jl. Bone Marrow Transplant. 2005 Mar;35(6):557-66. doi: 10.1038/sj.bmt.1704789. Bone Marrow Transplant. 2005. PMID: 15665852
Low-Level Cytomegalovirus Antigenemia Promotes Protective Cytomegalovirus Antigen-Specific T Cells after Allogeneic Hematopoietic Cell Transplantation.
Chen GL, Wallace PK, Zhang Y, Tario JD Jr, Przespolewski AC, Becker J, Almyroudis NG, Ross M, Riches M, Segal BH, Brix L, McCarthy PL, Hahn T. Chen GL, et al. Among authors: becker j. Biol Blood Marrow Transplant. 2020 Nov;26(11):2147-2154. doi: 10.1016/j.bbmt.2020.07.024. Epub 2020 Jul 25. Biol Blood Marrow Transplant. 2020. PMID: 32721522 Free PMC article.
Short-Term Storage of Mobilized Peripheral Blood Stem Cells in a Closed System Changes the Microenvironment and May Affect the Quantity of CD34+ and CD34+CD38-CD45RA-CD90+ Cells.
Elshoury A, Maguire O, Conway A, Tario J, Soh KT, Ross M, Hahn T, Becker J, Wallace P, McCarthy PL, Minderman H, Chen GL. Elshoury A, et al. Among authors: becker j. Transplant Cell Ther. 2023 Feb;29(2):112.e1-112.e9. doi: 10.1016/j.jtct.2022.11.021. Epub 2022 Nov 24. Transplant Cell Ther. 2023. PMID: 36436782 Free PMC article.
5,080 results